home / stock / axim / axim news

AXIM News and Press, Axim Biotechnologies Inc From 05/13/20

Stock Information
Company Name: Axim Biotechnologies Inc
Stock Symbol: AXIM
Market: OTC
Website: aximbiotech.com
Menu
AXIM AXIM Quote AXIM Short AXIM News AXIM Articles AXIM Message Board
Get AXIM Alerts

News, Short Squeeze, Breakout and More Instantly...
AXIM - AXIM® Biotechnologies Issues Update Letter to Shareholders

SAN DIEGO, May 13, 2020 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc . (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and cannabinoid research, anno...
AXIM - Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Files New U.S. Patent Application for Water-Soluble Cannabinoid Molecules

SAN DIEGO , May 5, 2020 /PRNewswire/ --  Medical Marijuana, Inc.  (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, an...

AXIM - AXIM® Biotechnologies Files New U.S. Patent Application for Water-Soluble Cannabinoid Molecules

NEW YORK, April 28, 2020 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTC: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and cannabinoid research, announced to...

AXIM - Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Receives New U.S. Patent Issuance for Chewing Gum Comprising Cannabinoids and Nicotine

SAN DIEGO , April 8, 2020 /PRNewswire/ --  Medical Marijuana, Inc.  (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, ann...
AXIM - AXIM® Biotechnologies Receives New U.S. Patent Issuance for Chewing Gum Comprising Cannabinoids and Nicotine to Treat or Alleviate Tobacco Smoking

NEW YORK, April 07, 2020 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and cannabinoid research, announced ...

AXIM - AXIM® Biotechnologies Completes Pre-Clinical Drug Studies on New Compound Proving Tenfold Greater Inhibition of Tumor Metastasis Than Parent Compound

SAN DIEGO, March 24, 2020 (GLOBE NEWSWIRE) -- AXIM ®  Biotechnologies, Inc . (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and cannabinoid re...

AXIM - Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Completes Acquisition of Oncology Research and Development Company Sapphire Biotech, Inc.

SAN DIEGO , March 24, 2020 /PRNewswire/ --  Medical Marijuana, Inc.  (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, annou...
AXIM - AXIM® Biotechnologies Completes Acquisition of Oncology Research and Development Company Sapphire Biotech, Inc.

NEW YORK, March 18, 2020 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc.  (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and cannabinoid research, a...

AXIM - AXIM® Biotechnologies Nutraceutical Division Announces Launch of CBD-Based Gum for Professional and Amateur Golfers

NEW YORK, Feb. 26, 2020 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and cannabinoid research, announc...

AXIM - Axim® Biotechnologies Completes First Phase of Pharmacokinetic Clinical Study on Cannabinoid-Based Gum With Dronabinol

NEW YORK, Feb. 18, 2020 (GLOBE NEWSWIRE) -- AXIM ®  Biotechnologies, Inc.  (OTCQB: AXIM) (“AXIM ® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and cannabinoid researc...
Previous 10 Next 10